Lymphocyte activation in the pathogenesis of psoriasis

被引:56
作者
Norris, DA
Travers, JB
Leung, DYM
机构
[1] INDIANA UNIV HOSP,DEPT DERMATOL,INDIANAPOLIS,IN 46202
[2] NATL JEWISH CTR IMMUNOL & RESP MED,DIV PEDIAT ALLERGY IMMUNOL,DENVER,CO 80206
关键词
D O I
10.1111/1523-1747.ep12276285
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1 / 4
页数:4
相关论文
共 30 条
[1]   GROUP-A STREPTOCOCCAL ANTIGEN-SPECIFIC-T LYMPHOCYTES IN GUTTATE PSORIATIC LESIONS [J].
BAKER, BS ;
BOKTH, S ;
POWLES, A ;
GARIOCH, JJ ;
LEWIS, H ;
VALDIMARSSON, H ;
FRY, L .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (05) :493-499
[2]  
BAKER BS, 1984, BRIT J DERMATOL, V110, P555
[3]  
BARKER J N W N, 1991, Journal of Dermatological Science, V2, P106, DOI 10.1016/0923-1811(91)90019-T
[4]   Pulling the trigger on psoriasis [J].
Boehncke, WH ;
Dressel, D ;
Zollner, TM ;
Kaufmann, R .
NATURE, 1996, 379 (6568) :777-777
[5]   T-CELL-RECEPTOR REPERTOIRE IN CHRONIC PLAQUE-STAGE PSORIASIS IS RESTRICTED AND LACKS ENRICHMENT OF SUPERANTIGEN-ASSOCIATED V-BETA REGIONS [J].
BOEHNCKE, WH ;
DRESSEL, D ;
MANFRAS, B ;
ZOLLNER, TM ;
WETTSTEIN, A ;
BOHM, BO ;
STERRY, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (05) :725-728
[6]   CD8+ T-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTOR V(BETA)3 AND/OR V(BETA)13.1 GENES [J].
CHANG, JCC ;
SMITH, LR ;
FRONING, KJ ;
SCHWABE, BJ ;
LAXER, JA ;
CARALLI, LL ;
KURLAND, HH ;
KARASEK, MA ;
WILKINSON, DI ;
CARLO, DJ ;
BROSTOFF, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9282-9286
[7]   OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS IN PSORIASIS [J].
DETMAR, M ;
BROWN, LF ;
CLAFFEY, KP ;
YEE, KT ;
KOCHER, O ;
JACKMAN, RW ;
BERSE, B ;
DVORAK, HF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1141-1146
[8]   Staphylococcal toxins and protein a differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes [J].
Ezepchuk, YV ;
Leung, DYM ;
Middleton, MH ;
Bina, P ;
Reiser, R ;
Norris, DA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (04) :603-609
[9]   RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS [J].
GOTTLIEB, SL ;
GILLEAUDEAU, P ;
JOHNSON, R ;
ESTES, L ;
WOODWORTH, TG ;
GOTTLIEB, AB ;
KRUEGER, JG .
NATURE MEDICINE, 1995, 1 (05) :442-447
[10]   ORAL CYCLOSPORINE IN THE TREATMENT OF INFLAMMATORY AND NONINFLAMMATORY DERMATOSES - A CLINICAL AND IMMUNOPATHOLOGIC ANALYSIS [J].
GUPTA, AK ;
ELLIS, CN ;
NICKOLOFF, BJ ;
GOLDFARB, MT ;
HO, VC ;
ROCHER, LL ;
GRIFFITHS, CEM ;
COOPER, KD ;
VOORHEES, JJ .
ARCHIVES OF DERMATOLOGY, 1990, 126 (03) :339-350